MEDIFAST INC (MED) › Cost of RevenueMEDIFAST INC (MED) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2009: $45.35M2010: $65.08M2011: $73.69M2012: $82.66M2013: $83.49M2014: $76.08M2015: $71.46M2016: $68.87M2017: $73.75M2018: $121.10M2019: $176.81M2020: $237.03M2021: $398.49M2022: $458.16M2023: $296.20M2024: $157.84M2025: $110.60M$110.60M2009Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$110.60M-29.9%2024$157.84M-46.7%2023$296.20M-35.3%2022$458.16M+15.0%2021$398.49M+68.1%2020$237.03M+34.1%2019$176.81M+46.0%2018$121.10M+64.2%2017$73.75M+7.1%2016$68.87M-3.6%2015$71.46M-6.1%2014$76.08M-8.9%2013$83.49M+1.0%2012$82.66M+12.2%2011$73.69M+13.2%2010$65.08M+43.5%2009$45.35M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share